dan 2163 has been researched along with levodopa in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Marti, M; Morari, M; Viaro, R | 1 |
| de Greck, M; Deppert, V; Grimm, O; Kopfer, V; Kuhn, M; Küpper-Tetzel, L; Reif, A | 1 |
| de Greck, M; Grimm, O; Küpper-Tetzel, L; Nägele, M; Plichta, M; Reif, A | 1 |
2 trial(s) available for dan 2163 and levodopa
| Article | Year |
|---|---|
Amisulpride and l-DOPA modulate subcortical brain nuclei connectivity in resting-state pharmacologic magnetic resonance imaging.
Topics: Adolescent; Adult; Amisulpride; Basal Ganglia; Brain Mapping; Dopamine Agents; Double-Blind Method; Female; Healthy Volunteers; Humans; Impulsive Behavior; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Movement; Neural Pathways; Rest; Ventral Tegmental Area; Young Adult | 2020 |
No effect of a dopaminergic modulation fMRI task by amisulpride and L-DOPA on reward anticipation in healthy volunteers.
Topics: Adult; Amisulpride; Anticipation, Psychological; Brain; Cross-Over Studies; Dopamine; Dopamine Agonists; Double-Blind Method; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Motivation; Reward; Young Adult | 2021 |
3 other study(ies) available for dan 2163 and levodopa
| Article | Year |
|---|---|
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockade.
Topics: Amisulpride; Animals; Antiparkinson Agents; Benzimidazoles; Benzothiazoles; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Drug Synergism; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neural Inhibition; Nociceptin; Opioid Peptides; Parkinsonian Disorders; Piperidines; Pramipexole; Pyridines; Reaction Time; Receptors, Dopamine D3; Sulpiride | 2010 |